HTA143 Are HTA Agencies Willing to Accept Single-Arm Trials as the Main Source of Clinical Evidence for the Assessment of Pediatric Orphan Drugs When Faced With Extenuating Ethical and Medical Circumstances?
Abstract
Authors
M Barchanska C Shaw J Campbell L Perez